ICRM
CHE icon

Insight Capital Research & Management’s Chemed CHE Stock Holding History

Insight Capital Research & Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-5,925
Closed -$429K – 182
2013
Q2 		$429K Buy
+5,925
New +$435K 0.11% 158

Other funds holding CHE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Insight Capital Research & Management's CHE Position: Q3 2013 in Review

Insight Capital Research & Management sold out of Chemed (CHE) in Q3 2013, closing a stake of 5,925 shares — an estimated $429K sold.

Insight Capital Research & Management first reported a position in CHE in Q2 2013 and held it in 1 quarter. The position peaked at $429K in Q2 2013. 178 funds tracked by Wall St. Rank hold CHE as of Q3 2013.

  • Insight Capital Research & Management reported no remaining Chemed position as of Q3 2013 after selling out during the quarter.
  • Insight Capital Research & Management sold 5,925 Chemed shares in Q3 2013, an estimated $429K.
  • Insight Capital Research & Management first reported a position in Chemed in Q2 2013 and held it in 1 quarter.
  • Insight Capital Research & Management's Chemed position peaked at $429K in Q2 2013.
  • 178 funds tracked by Wall St. Rank held Chemed as of Q3 2013.

Based on Insight Capital Research & Management's 13F filing for Q3 2013, filed 13 Nov 2013.